Genie Energy Q3 Earnings Fall Y/Y on Cost Pressures, Revenues Rise — Negative

GNE   Zacks Investment Research — November 05, 2025

GNE's Q3 revenues jump 24% y/y, but rising energy costs squeezed margins and cut profits, prompting cautious guidance for the rest of 2025.

image for news Genie Energy Q3 Earnings Fall Y/Y on Cost Pressures, Revenues Rise

Here is Why Growth Investors Should Buy Fabrinet (FN) Now — Positive

FN   Zacks Investment Research — November 05, 2025

Fabrinet (FN) could produce exceptional returns because of its solid growth attributes.

image for news Here is Why Growth Investors Should Buy Fabrinet (FN) Now

Here is Why Growth Investors Should Buy Flowserve (FLS) Now — Positive

FLS   Zacks Investment Research — November 05, 2025

Flowserve (FLS) could produce exceptional returns because of its solid growth attributes.

image for news Here is Why Growth Investors Should Buy Flowserve (FLS) Now

Is Commercial Metals (CMC) a Solid Growth Stock? 3 Reasons to Think "Yes" — Positive

CMC   Zacks Investment Research — November 05, 2025

Commercial Metals (CMC) is well positioned to outperform the market, as it exhibits above-average growth in financials.

image for news Is Commercial Metals (CMC) a Solid Growth Stock? 3 Reasons to Think "Yes"

Here is Why Growth Investors Should Buy Interface (TILE) Now — Positive

TILE   Zacks Investment Research — November 05, 2025

Interface (TILE) could produce exceptional returns because of its solid growth attributes.

image for news Here is Why Growth Investors Should Buy Interface (TILE) Now

Looking for a Growth Stock? 3 Reasons Why Vital Farms (VITL) is a Solid Choice — Positive

VITL   Zacks Investment Research — November 05, 2025

Vital Farms (VITL) possesses solid growth attributes, which could help it handily outperform the market.

image for news Looking for a Growth Stock? 3 Reasons Why Vital Farms (VITL) is a Solid Choice

GoodRx Sees ‘Profund Transformation' in Prescriptions With TrumpRx — Positive

GDRX   PYMNTS — November 05, 2025

GoodRx CEO Wendy Barnes sees a “profound transformation” happening in prescription drug pricing. The catalyst, Barnes said during an earnings call Wednesday (Nov. 3), is the pending launch of TrumpRx, the planned government-run prescription drug website.

image for news GoodRx Sees ‘Profund Transformation' in Prescriptions With TrumpRx

CARLSBAD, Calif.--(BUSINESS WIRE)-- #3E--3E, a leading global provider of regulatory expertise and intelligent product compliance solutions, today announced the formal extension of its long-term partnership with SAP, reaffirming both companies' commitment to co-innovation and customer success. Under the extended collaboration, 3E will continue to deliver embedded regulatory content for SAP® S/4HANA® for product compliance, while supporting expanded commercial models and initiatives designed to empowe.

image for news 3E and SAP Extend Partnership to Deliver Next-Generation Product Compliance Solutions for Global Supply Chains

NEW YORK, NY / ACCESS Newswire / November 5, 2025 / There's a moment in every company's life when the work stops feeling experimental and starts feeling inevitable. SMX (NASDAQ:SMX) just hit that moment.

image for news From Singapore to Spain to France to the United States, the World's "Proof" Economy is Being Built by SMX

Final Trades: Welltower, Dell, Microsoft, and the IYC — Neutral

DELL  IYC  MSFT  WELL   CNBC Television — November 05, 2025

The Investment Committee give you their top stocks to watch for the second half.

image for news Final Trades: Welltower, Dell, Microsoft, and the IYC

Emerson Q4 Earnings Match Estimates, Software and Control Sales Rise — Positive

EMR   Zacks Investment Research — November 05, 2025

EMR posts solid Q4 results with stronger margins and upbeat FY26 guidance, driven by Software & Control growth.

image for news Emerson Q4 Earnings Match Estimates, Software and Control Sales Rise

Recent Price Trend in Castle Biosciences (CSTL) is Your Friend, Here's Why — Positive

CSTL   Zacks Investment Research — November 05, 2025

Castle Biosciences (CSTL) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

image for news Recent Price Trend in Castle Biosciences (CSTL) is Your Friend, Here's Why

Skyworks Q4 Earnings Top Estimates, Revenues Grow Y/Y, Shares Rise — Positive

SWKS   Zacks Investment Research — November 05, 2025

SWKS tops Q4 forecasts with double-digit earnings growth and upbeat guidance for its Broad markets segment.

image for news Skyworks Q4 Earnings Top Estimates, Revenues Grow Y/Y, Shares Rise

MPLX Beats Q3 Earnings Estimates, Hikes Quarterly Distribution — Positive

MPLX   Zacks Investment Research — November 05, 2025

MPLX posts strong Q3 results with higher earnings and revenues, and a 12.5% distribution hike amid volume and rate gains.

image for news MPLX Beats Q3 Earnings Estimates, Hikes Quarterly Distribution

Columbus McKinnon (CMCO) Shows Fast-paced Momentum But Is Still a Bargain Stock — Positive

CMCO   Zacks Investment Research — November 05, 2025

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Columbus McKinnon (CMCO) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

image for news Columbus McKinnon (CMCO) Shows Fast-paced Momentum But Is Still a Bargain Stock

Select Medical (SEM) Is Attractively Priced Despite Fast-paced Momentum — Positive

SEM   Zacks Investment Research — November 05, 2025

Select Medical (SEM) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

image for news Select Medical (SEM) Is Attractively Priced Despite Fast-paced Momentum

Newmark Group (NMRK) Is Attractively Priced Despite Fast-paced Momentum — Positive

NMRK   Zacks Investment Research — November 05, 2025

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Newmark Group (NMRK) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

image for news Newmark Group (NMRK) Is Attractively Priced Despite Fast-paced Momentum

American Financial Group, Inc. (AFG) Q3 2025 Earnings Call Transcript — Neutral

AFG  AFGE   Seeking Alpha — November 05, 2025

American Financial Group, Inc. ( AFG ) Q3 2025 Earnings Call November 5, 2025 11:30 AM EST Company Participants Diane P. Weidner - Vice President of Investor & Media Relations Carl Lindner - Co-CEO & Director Craig Lindner - Co-CEO & Director Brian Hertzman - Senior VP & CFO Conference Call Participants Michael Zaremski - BMO Capital Markets Equity Research Andrew Andersen - Jefferies LLC, Research Division Meyer Shields - Keefe, Bruyette, & Woods, Inc., Research Division Presentation Operator Good day, and thank you for standing by.

image for news American Financial Group, Inc. (AFG) Q3 2025 Earnings Call Transcript

Why Fast-paced Mover American Eagle (AEO) Is a Great Choice for Value Investors — Positive

AEO   Zacks Investment Research — November 05, 2025

American Eagle (AEO) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

image for news Why Fast-paced Mover American Eagle (AEO) Is a Great Choice for Value Investors

trivago N.V. (TRVG) Q3 2025 Earnings Call Transcript — Neutral

TRVG   Seeking Alpha — November 05, 2025

trivago N.V. ( TRVG ) Q3 2025 Earnings Call November 5, 2025 8:15 AM EST Company Participants Johannes Thomas - MD, Member of Management Board & CEO Wolf Schmuhl - CFO, MD & Member of Management Board Conference Call Participants Wyatt Swanson - D.A.

image for news trivago N.V. (TRVG) Q3 2025 Earnings Call Transcript